Nuclear Medicine Equipment Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Global Nuclear Medicine 
Equipment Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r e po r t  by  I M ARC G r oup ,  t i t l ed  " Nu c l ea r  M ed i c i ne  
Equ i p me nt  M ar ke t :  G l ob a l  I nd ust ry  T rend s ,  Sha re ,  S i ze ,  G r ow t h ,  O ppo r t un i t y  
and  F oreca s t  20 24 - 2 032 , "  t he  g loba l  nu c lea r  m e d ic ine  e qu ipm en t  m ar ke t  s i ze  
r eac hed  US$  3 . 1  B i l l i on  i n  2023 .
Nuc le a r  m ed ic in e  i s  a  b r anc h  o f  r ad io lo gy  t ha t  i s  used  f o r  v i su a l i z i ng  t h e  f unc t i on  
Report and  s t r uc t u r e  o f  a  t i s sue ,  bo ne ,  s ys t e m  o r  o r ga n .  I t  i nc lu des  va r i o us  t h e r ap ie s ,  s uch  
as  r ad ioa c t i ve  i od ine ,  an t i bod ie s ,  ph ospho r us  a nd  o t he r  m a t e r i a l s  t he r apy .  Nuc l ea r  
Highlight and m ed ic ine  t he r ap ies  a r e  p e r f o r m ed  by  i n t r oduc i ng  r a d ionu c l i des  o r  r ad io pha r m ace u t i ca l s  i n t o  t he  body .  
The  be hav io r  o f  t he  r ad ionuc l i de  i s  m ea su r ed  t h r ough  a  gam m a cam er a ,  gene r a t o r ,  
Description nuc le a r  r eac t o r ,  and  cyc lo t r on .  N uc lea r  m ed ic ine  i s  us ed  f o r  d ia gnos ing  va r i ous  
con d i t i ons ,  wh ich  i nc lud e  b r a in  t um or s ,  and  p r os t a t e ,  b r ea s t ,  l ung ,  a nd  h ead  a nd  
nec k  can ce r s .  Bes i des  t h i s ,  i t  a l so  he l ps  t o  de t ec t  o r ga n  en la r gem e n t ,  h em a t om a s ,  
cys t s ,  i n f ec t i o ns ,  a r t h r i t i s ,  and  f r ac t u r es .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / nuc lea r - m ed ic ine - eq u ipm en t - m ar k e t / r eque s t sam p le
Report Description
Global  Nuc lear  Medi c i ne  Equ i pment  Market  T rends:
The  r i s i ng  p reva lence o f  hea r t - based  d iseases ,  neuro log ica l  d i so rde rs ,  and  cancers  has  led  to  an  i nc rease  in  t he  
awareness  rega rd ing  t he  impor t ance o f  ea r l y  d iagnos is ,  wh ich  i s  p r imar i l y  d r i v i ng  the  marke t  g rowt h .  The  r i s ing  
awareness  i s  f u r t he r  lead ing  t o  the  w idesp read  es t ab l i shmen t  o f  d iagnos t i c  cen t e rs ,  wh ich  i s  f ue l ing  t he  dem and f o r  
t hese  sys tems.  O t he r  t han  th is ,  va r ious  t echno log ica l  advancement s  a re  con t r ibu t i ng  t o  the  g row th  o f  t he  marke t .  
Fo r  ins t ance,  lead ing  p laye rs  have  been  deve lop ing  modern  so f tware  t ha t  he lps  t o  improve  the  acqu is i t i on ,  and  image  
de ta i l  and  sha rpness  o f  gamma and pos i t r on  emiss ion  t omography  (PET)  cameras .  Moreover ,  s ign i f i can t  
improvemen ts  in  t he  hea l thca re  in f r as t ruc t u re ,  and  a  rap id  sh i f t  t oward  h igh- reso lu t i on  imag ing  so lu t i ons  a re  some o f  
t he  o t he r  f ac t o rs  tha t  a re  c rea t i ng  a  pos i t i ve  ou t l ook  fo r  t he  marke t .
Look ing  fo rward ,  the  market  i s  p ro jected  to  reach  US$ 5 .2  Bi l l ion  by 2032,  expand i ng  at  a  CAGR of  5 .8% dur ing  
the  fo recast  per iod  (2024-2032) .
V i ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/nucl ear -medi c ine -equ i pment -market
Breakup by Product:
• Single-Photon Emiss ion Computed Tomography
o Standalone
o Hybrid
• Positron Emission Tomography
o Standalone
Report o Hybrid
Segmentation • Planar Scint igraphy
 
Breakup by Mode of Application:
• Neurology
• Oncology
• Cardiology
• Others
Breakup by End User:
• Hospitals
• Imaging Centers
• Academic and Research Insti tutes
• Others
Report 
Breakup by Region:
Segmentation
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Biodex Medical  Systems Inc.  (Mir ion 
Technologies Inc.)
• Cardinal  Health Inc.
• CMR Naviscan Corporat ion
Competitive • DDD-Diagnost ic A/S
• Digirad Corporat ion
Landscape 
• General  E lectr ic Company
with Key • Koninkl i jke Phi l ips N.V.
Players • Mediso Ltd.
• Neusoft  Corporat ion
• Siemens AG
• SurgicEye GmbH
• Toshiba Corporat ion.
How has the global nuclear medicine equipment 
market performed so far and how will it perform in 
the coming years?
What has been the impact of COVID-19 on the 
global nuclear medicine equipment market?
Key 
What are the key regional markets?
Questions 
Answered in What is the breakup of the market based on the product?
the Report
What is the breakup of the market based on the 
application?
What is the breakup of the market based on the 
end user?
What are the various stages in the value chain of 
the industry?
What are the key driving factors and challenges in 
the industry?
Key What is the structure of the global nuclear 
medicine equipment market and who are the key 
players?
Questions 
Answered in What is the degree of competition in the industry?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  N u c l e a r  M e d i c i n e  E q u i p m e n t  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     S i n g l e - P h o t o n  E m i s s i o n  C o m p u t e d  T o m o g r a p h y
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  S t a n d a l o n e
           6 . 1 . 2 . 2  H y b r i d
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     P o s i t r o n  E m i s s i o n  T o m o g r a p h y
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
       
           6 . 2 . 2 . 1  S t a n d a l o n e
           6 . 2 . 2 . 2  H y b r i d
        6 . 2 . 3  M a r k e t  F o r e c a s t
    6 . 3     P l a n a r  S c i n t i g r a p h y
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     N e u r o l o g y
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
Table of     7 . 2     O n c o l o g y        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     C a r d i o l o g y
Contents         7 . 3 . 1  M a r k e t  T r e n d s        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     I m a g i n g  C e n t e r s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     A c a d e m i c  a n d  R e s e a r c h  I n s t i t u t e s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / n u c l e a r- m e d i c i n e - e q u i p me n t - m a r ke
t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: